Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GP 1a is a potent agonist of cannabinoid receptor 2 (CB2) (EC50=7.1), as shown in cAMP, GTPγS and β-arrestin recruitment assays. GP 1a is approximately 30-fold more selective for CB2 receptors than CB1 receptors and increases P-ERK1/2 expression in HL-60 cells in vitro. GP 1a is beneficial for skin wound healing. GP 1a inhibits inflammation and fibrogenesis while promoting epithelial re-formation.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 51.00 | |
5 mg | In stock | $ 113.00 | |
10 mg | In stock | $ 178.00 | |
25 mg | In stock | $ 359.00 | |
50 mg | In stock | $ 533.00 | |
100 mg | In stock | $ 759.00 | |
500 mg | In stock | $ 1,530.00 |
Description | GP 1a is a potent agonist of cannabinoid receptor 2 (CB2) (EC50=7.1), as shown in cAMP, GTPγS and β-arrestin recruitment assays. GP 1a is approximately 30-fold more selective for CB2 receptors than CB1 receptors and increases P-ERK1/2 expression in HL-60 cells in vitro. GP 1a is beneficial for skin wound healing. GP 1a inhibits inflammation and fibrogenesis while promoting epithelial re-formation. |
Molecular Weight | 441.35 |
Formula | C23H22Cl2N4O |
CAS No. | 511532-96-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 90.0 mg/mL (203.9 mM)
DMSO: 90.0 mg/mL (203.9 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GP 1a 511532-96-0 Apoptosis GPCR/G Protein PERK Arrestin Cannabinoid Receptor inhibitor inhibit